Dicarb-Inga Syrup 100 ml

Babies: Safe in babies. Consult your doctor before using this medication on babies.
Lactating mothers: Consult your doctor before using this medicine, as human and animal studies are unavailable. Pregnancy: Consult your doctor before using this medicine, as human and animal studies are not available.
Driving: Avoid driving as it alters vision, alertness or you may feel dizzy and sleepy. Alcohol: Avoid alcohol consumption while using these medicines as it may cause excessive drowsiness and calmness.
Kidney: Caution while using in kidney disease patients. Avoid severe renal impairment conditions.
Liver: Consult your doctor if you have liver diseases before using this medication. .

Sleepiness Skin rashes Visual disturbances Fever Nausea and vomiting Hair loss Abnormal liver function tests Headache Abdominal discomfort Vertigo.

Dicarb syrup activates the immune system and enhances the phagocytosis of worms. It works by killing and preventing the growth of worms, thereby treating worm infections like filariasis..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take the medication as prescribed by your doctor • Take this medication with food and at exact times every day • Complete the course as prescribed without skipping and don’t stop it if you feel better before the completion of the course • Shake the container and measure the syrup as prescribed before taking • You require routine monitoring of blood and liver function tests throughout the course • If you develop signs of infections, consult a medical care • Inform your physician if you have seizures • This drug may make you feel dizzy and sleepy. In these conditions, avoid driving and handling machinery.

Major • Dicarb + Acebutolol: Concurrent use may lead to increased risk of bradycardic activities of acebutolol • Dicarb + Aclidinium: Concurrent use may lead to increased risk of neuromuscular blocking activities of aclidinium • Dicarb + Amitriptyline: Concurrent use may lead to the decreased therapeutic efficacy of amitriptyline • Dicarb + Atropine: Concurrent use may lead to the decreased therapeutic efficacy of atropine • Dicarb + Bisoprolol: Concurrent use may lead to increased risk of bradycardic activities of bisoprolol • Dicarb + Cocaine: Concurrent use may lead to increased risk of neuromuscular blocking activities of cocaine • Dicarb + Deflazacort: Concurrent use may lead to the decreased therapeutic efficacy of deflazacort • Dicarb + Flavoxate: Concurrent use may lead to the decreased therapeutic efficacy of flavoxate.